#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

The role of nutrition in prevention of cognitive decline in the old age.


Authors: E. Topinková;  T. Richter
Published in: Geriatrie a Gerontologie 2016, 5, č. 1: 34-38
Category: Review Article

Overview

The article reviews current views on the effect of nutrition on maintaining cognitive functions in old age. It focuses mainly on nutritional strategies based on clinical studies which support the effectiveness of selected nutrients supplementation and diets on prevention of cognitive decline in cognitively intact general older population, in patients with dementia and Alzheimer´s disease and in patients with Mild Cognitive Impairment.

KEYWORDS:
ageing – cognitive impairment – dementia – nutrition – prevention


Sources

1. Middleton LE, Yaffe K. Promising strategies for the prevention of dementia. Arch Neurol 2009; 66(10):1210–1215.

2. Gustafson DR, Morris MC, Scarmeas N, et al. New Perspectives on Alzheimer’s Disease and Nutrition. Journal of Alzheimer’s Disease 2015; 46(4): 1111–1127.

3. Besser LM, Gill DP, Monsell SE, et al. Body mass index, weight change, and clinical progression in mild cognitive impairment and Alzheimer disease. Alzheimer Dis Assoc Disord 2014; 28(1):36–43.

4. Droogsma E, van Asselt DZB, Scholzel-Dorenbos CJM, et al. Nutritional status of community-dwelling elderly with newly diagnosed Alzheimer’s disease: prevalence of malnutrition and the relation of various factors to nutritional status. J Nutr Health Aging 2013; 17(7): 606–10.

5. Vellas B, Lauque S, Gillette-Guyonnet S, et al. Impact of nutritional status on the evolution of Alzheimer’s disease and on response to acetylcholinesterase inhibitor treatment. J Nutr Health Aging 2005; 9(2): 75–80.

6. Navrátilová M, Jarkovský J, Hamrová M, Leonard B. Alzheimer Disease: Malnutrition and Nutritional Support - comprative and intervention study. Vnitř lék 2007; 53(9): 53–54

7. Trushina E, Dutta T, Persson X-MT, et al. Identification of altered metabolic pathways in plasma and CSF in mild cognitive impairment and Alzheimer’s disease using metabolomics. PLoS One 2013; 8(5): e63644.

8. Lopes da Silva S, Vellas B, Elemenas S, et al. Plasma nutrient status of patients with Alzheimer’s disease: Systematic review and meta-analysis. Alzheimers Dement 2014;10(4): 485–502.

9. Sofi F, Abbate R, Gensini GF, Casini A. Accruing evidence on benefits of adherence to the Mediterranean diet on health: an updated systematic review and meta-analysis. Am J Clin Nutr 2010; 92(5): 1189–1196.

10. Feart C, Peres K, Samieri C, et al., Adherence to a Mediterranean diet, cognitive decline, and risk of dementia. JAMA 2009; 302(6): 638–648.

11. Tangney CC, Kwasny MJ, Hong Li, et al. Adherence to a Mediterranean-type dietary pattern and cognitive decline in a community population. Am J Clin Nutr 2011; 93(3): 601–607.

12. Wengreen H, Munger RG, Cutler A, et al. Prospective study of Dietary Approaches to Stop Hypertension- and Mediterranean-style dietary patterns and age-related cognitive change: the Cache County Study on Memory, Health and Aging. Am J Clin Nutr 2013; 98(5): 1263–1271.

13. Psaltopoulou T, Sergentanis TN, Panagiotakos DB, et al., Mediterranean diet, stroke, cognitive impairment, and depression: A meta-analysis. Ann Neurol 2013;74(4): 580–591.

14. Singh, B et al.,Association of mediterranean diet with mild cognitive impairment and Alzheimer’s disease: a systematic review and meta-analysis. J Alzheimers Dis 2014; 39(2): 271–282.

15. Martinez-Lapiscina EH, Clavero P, Toledo E, et al., Mediterranean diet improves cognition: the PREDIMED-NAVARRA randomised trial. J Neurol Neurosurg Psychiatry, 2013; 84(12): 1318–1325.

16. Ngandu T, Lehtisalo J, Solomon A, et al. A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial. Lancet 2015; 385(9984): 2255–2263.

17. Lang I, Wallace RB, Huppert F, Melzer D. Moderate alcohol consumption in older adults is associated with better cognition and well-being than abstinence. Age Ageing 2007; 36(3): 256–261.

18. Stampfer MJ, Kang HJ, Chen J, et al., Effects of moderate alcohol consumption on cognitive function in women. N Engl J Med 2005; 352(3): 245–253.

19. Downer B, Zanjani F, Fardo DW. The relationship between midlife and late life alcohol consumption, APOE e4 and the decline in learning and memory among older adults. Alcohol Alcohol 2014; 49(1):17–22.

20. Harrison FE. A critical review of vitamin C for the prevention of age-related cognitive decline and Alzheimer’s disease. J Alzheimers Dis 2012; 29(4):711–726.

21. Joshi YB, Pratico D. Vitamin E in aging, dementia, and Alzheimer’s disease. Biofactors 2012; 38(2): 90–97.

22. Dysken MW Sano M, Asthana, S et al. Effect of vitamin E and memantine on functional decline in Alzheimer disease: the TEAM-AD VA cooperative randomized trial. JAMA 2014; 311(1):33–44.

23. Morris MS, Selhub J, Jacques PF. Vitamin B-12 and folate status in relation to decline in scores on the mini-mental state examination in the Framingham heart study. J Am Geriatr Soc 2012; 60(8):1457–1464.

24. Malouf R., Grimley Evans J. The effect of vitamin B6 on cognition. Cochrane Database Syst Rev 2003;(4): p. CD004393.

25. Aisen PS, Schneider LS, Sano M, et al. High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial. JAMA 2008; 300(15): 1774–1783

26. Anastasiou CA, Yannakoulia M, Scarmeas N. Vitamin D and cognition: an update of the current evidence. J Alzheimers Dis 2014; 42 Suppl 3: S71–80.

27. Annweiler C, Dursun E, Feron F, et al. ‘Vitamin D and cognition in older adults’: updated international recommendations. J Intern Med 2015; 277(1): 45–57.

28. Snitz BE,O´Meara ES, Carlson MC, et al. Ginkgo biloba for preventing cognitive decline in older adults: a randomized trial. JAMA 2009; 302(24): 2663–2670.

29. Vellas B, Coley N, Ousset PJ, et al. Long-term use of standardised Ginkgo biloba extract for the prevention of Alzheimer’s disease (GuidAge): a randomised placebo-controlled trial. Lancet Neurol 2012; 11(10): 851–859.

30. Birks J, Grimley Evans J. Ginkgo biloba for cognitive impairment and dementia. Cochrane Database Syst Rev 2009; (1): p. CD003120.

31. Polidori MC, Pratico D, Mangialasche F, et al. High fruit and vegetable intake is positively correlated with antioxidant status and cognitive performance in healthy subjects. J Alzheimers Dis 2009; 17(4): 921–927.

32. Zanotta D, Puricelli S, Bonoldi G. Cognitive effects of a dietary supplement made from extract of Bacopa monnieri, astaxanthin, phosphatidylserine, and vitamin E in subjects with mild cognitive impairment: a noncomparative, exploratory clinical study. Neuropsychiatr Dis Treat 2014; 10: 225–230.

33. Cederholm T, Palmblad J. Are omega-3 fatty acids options for prevention and treatment of cognitive decline and dementia? Curr Opin Clin Nutr Metab Care 2010; 13(2): 150–155.

34. Freund-Levi Y, Eriksdotter-Jönhagen M, Cederholm T, et al., Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial. Arch Neurol 2006; 63(10):1402–1408.

35. Sinn N, Milte CM, Street S, et al. Effects of n-3 fatty acids, EPA v. DHA, on depressive symptoms, quality of life, memory and executive function in older adults with mild cognitive impairment: a 6-month randomised controlled trial. Br J Nutr 2012; 107(11): 1682–1693.

36. Wandevoude M, Barber-Gateau P, Cederholm T, et al. Healthy brain ageing and cognition: nutritional factors. Eur Ger Med 2016, DOI: 10.1016/j.eurger.2015.12.005

37. Mecocci P, Tinarelli C, Schulz RJ, Polidori MC. Nutraceuticals in cognitive impairment and Alzheimer’s disease. Front Pharmacol 2014; 5: 147. doi: 10.3389/fphar.2014.00147

38. Scheltens P, Kamphuis PJ, Verhey FR, et al., Efficacy of a medical food in mild Alzheimer’s disease: A randomized, controlled trial. Alzheimers Dement, 2010. 6(1): 1-10 e1. doi: 10.1016/j.jalz.2009.10.003.

39. Scheltens P, Twisk JWR, Blesa R, et al. Efficacy of Souvenaid in mild Alzheimer’s disease: results from a randomized, controlled trial. J Alzheimers Dis 2012; 31(1): 225–236.

40. Olde Rikkert MGM, Verhey FR, Blesa R, et al. Tolerability and safety of souvenaid in patients with mild Alzheimer’s disease: results of multi-center, 24-week, open-label extension study. J Alz Dis 2014. DOI: 10.3233/JAD-141305

Labels
Geriatrics General practitioner for adults Orthopaedic prosthetics
Topics Journals
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#